home / stock / prn:cc / prn:cc news

PRN:CC News and Press, Profound Medical Corp. From 01/27/26

Stock Information
Company Name: Profound Medical Corp.
Stock Symbol: PRN:CC
Market: TSXC
Website: profoundmedical.com
Menu
PRN:CC PRN:CC Quote PRN:CC Short PRN:CC News PRN:CC Articles PRN:CC Message Board
Get PRN:CC Alerts

News, Short Squeeze, Breakout and More Instantly...
PRN:CC - Profound Medical Announces Upcoming Investor Events

TORONTO, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for the ablation of diseased ti...
PRN:CC - Mount Sinai Becomes First in Metro New York to Deliver Incision-Free, MRI-Guided Prostate Treatment with TULSA-PRO®

Mount Sinai advances prostate care with AI-powered therapy designed to preserve continence and sexual function The Mount Sinai Hospital is ranked No. 6 nationally for Urology by US News & World Report ® for 2025-26 TORONTO, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Profound Medical...

PRN:CC - Profound Surpasses 2025 TULSA-PRO® Installed Base Goal

TORONTO, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for the ablation of diseased ti...

PRN:CC - Johns Hopkins Medicine Treats First Commercial TULSA-PRO® Case

TORONTO, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tiss...
PRN:CC - InvestorNewsBreaks - Profound Medical Corp. (NASDAQ: PROF; TSX: PRN) Closes $36 Million Registered Direct Offering

2025-12-31 09:05:00 ET This article has been disseminated on behalf of Profound Medical Corp. and may include paid advertising. Profound Medical Corp. (NASDAQ: PROF; TSX: PRN) announced the closing of its previously announced registered direct offering of 5,142,870 common sh...

PRN:CC - Profound Medical Corp. Announces Closing of Private Placement

TORONTO, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”) is pleased to announce that it has completed its previously announced private placement of common shares to Canadian investors (the “Offering...

PRN:CC - Profound Medical increases private placement to $6.45M

2025-12-24 14:10:26 ET More on Profound Medical Corp. Profound Medical Corp. (PRN:CA) Q3 2025 Earnings Call Transcript Profound Medical: Expectations Worsen Profound Medical announces pricing of up to $40 million financing Seeking Alpha’s Quant Rating ...
PRN:CC - Profound Medical Corp. Announces Upsize of Private Placement

TORONTO, Dec. 24, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”) is pleased to announce that it has increased the size of its private placement previously announced on December 19, 2025 (the “Offeringȁ...

PRN:CC - Profound Medical Corp. Closes $36 Million Registered Direct Offering; Expects to Complete Subsequent Private Placement On or Before December 30th

TORONTO, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”) today announced the closing of its previously announced registered direct offering of 5,142,870 common shares at a purchase price of $7.00 per share...

PRN:CC - Profound Medical announces pricing of up to $40 million financing

2025-12-19 09:15:30 ET More on Profound Medical Corp. Profound Medical Corp. (PRN:CA) Q3 2025 Earnings Call Transcript Profound Medical: Expectations Worsen Seeking Alpha’s Quant Rating on Profound Medical Corp. Historical earnings data for Profound Me...
Previous 10 Next 10